EMBL scientists have improved a protein analysis technique, significantly expanding its use and making it 100 times faster.
Both tobevibart (a monoclonal antibody) and elebsiran (a small interfering RNA) target hepatitis B virus surface antigen (HBsAg). Their efficacy and safety in the treatment of chronic hepatitis D ...
UK neurologists release new guidelines for JC virus testing in patients using the natalizumab biosimilar Tyruko, addressing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback